These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 400938

  • 41. The new beta-lactamases.
    Jacoby GA, Munoz-Price LS.
    N Engl J Med; 2005 Jan 27; 352(4):380-91. PubMed ID: 15673804
    [No Abstract] [Full Text] [Related]

  • 42. Clinical importance of inducible beta-lactamases in gram-negative bacteria.
    Sanders CC, Sanders WE.
    Eur J Clin Microbiol; 1987 Aug 27; 6(4):435-8. PubMed ID: 3311737
    [Abstract] [Full Text] [Related]

  • 43. Gram-negative bloodstream infections.
    Stryjewski ME, Boucher HW.
    Int J Antimicrob Agents; 2009 Aug 27; 34 Suppl 4():S21-5. PubMed ID: 19931812
    [Abstract] [Full Text] [Related]

  • 44. Epidemiology of beta-lactamases in Africa: correlation with resistance to beta-lactam antibiotics.
    Dowse LJ, Prigent BM.
    Clin Ther; 1991 Aug 27; 13(2):243-53. PubMed ID: 1863940
    [Abstract] [Full Text] [Related]

  • 45. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
    Sawai T, Yamaguchi A, Hiruma R.
    Rev Infect Dis; 1988 Aug 27; 10(4):761-4. PubMed ID: 3055174
    [Abstract] [Full Text] [Related]

  • 46. Binding of TEM-1 beta-lactamase to beta-lactam antibiotics by frontal affinity chromatography.
    Chen X, Li Y, Zhang Y, Yang J, Bian L.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr 15; 1051():75-83. PubMed ID: 28334649
    [Abstract] [Full Text] [Related]

  • 47. Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus.
    Sabath LD.
    Ann Intern Med; 1982 Sep 15; 97(3):339-44. PubMed ID: 6981367
    [Abstract] [Full Text] [Related]

  • 48. The emerging threat of acquired carbapenemases in Gram-negative bacteria.
    Cornaglia G, Rossolini GM.
    Clin Microbiol Infect; 2010 Feb 15; 16(2):99-101. PubMed ID: 20085603
    [No Abstract] [Full Text] [Related]

  • 49. [Beta-lactamases...until when?].
    Dorobăţ C, Dorobăţ G, Manciuc C, Vâţă A.
    Rev Med Chir Soc Med Nat Iasi; 2011 Feb 15; 115(3):647-55. PubMed ID: 22046767
    [Abstract] [Full Text] [Related]

  • 50. beta-Lactamases of gram-negative bacteria: new challenges for new drugs.
    Sanders CC.
    Clin Infect Dis; 1992 May 15; 14(5):1089-99. PubMed ID: 1600011
    [Abstract] [Full Text] [Related]

  • 51. Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratories. European Study Group on Antibiotic Resistance.
    Eur J Clin Microbiol; 1987 Oct 15; 6(5):515-20. PubMed ID: 3436313
    [Abstract] [Full Text] [Related]

  • 52. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.
    Pitout JD, Sanders CC, Sanders WE.
    Am J Med; 1997 Jul 15; 103(1):51-9. PubMed ID: 9236486
    [Abstract] [Full Text] [Related]

  • 53. Inducible type I beta-lactamases of gram-negative bacteria and resistance to beta-lactam antibiotics.
    Curtis NA, Eisenstadt RL, Rudd C, White AJ.
    J Antimicrob Chemother; 1986 Jan 15; 17(1):51-61. PubMed ID: 3485092
    [Abstract] [Full Text] [Related]

  • 54. Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase.
    Washington JA, Knapp CC, Sanders CC.
    Rev Infect Dis; 1988 Jan 15; 10(4):824-9. PubMed ID: 3263689
    [Abstract] [Full Text] [Related]

  • 55. Plasmid-mediated beta-lactam resistance in pathogenic gram-negative bacteria isolated in south India.
    Nandivada LS, Amyes SG.
    J Antimicrob Chemother; 1990 Aug 15; 26(2):279-90. PubMed ID: 2211459
    [Abstract] [Full Text] [Related]

  • 56. Beta-lactamases: current situation and clinical importance.
    Garau J.
    Intensive Care Med; 1994 Jul 15; 20 Suppl 3():S5-9. PubMed ID: 7962990
    [Abstract] [Full Text] [Related]

  • 57. In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases.
    Dornbusch K, Frolander F, Cacciapuoti AF, Naples L, Hare RS, Miller GH.
    J Antimicrob Chemother; 1985 Jun 15; 15 Suppl C():85-97. PubMed ID: 3897175
    [Abstract] [Full Text] [Related]

  • 58. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability.
    Stobberingh EE, Houben AW, van Boven CP.
    J Antimicrob Chemother; 1985 Jun 15; 15 Suppl C():73-83. PubMed ID: 3875605
    [Abstract] [Full Text] [Related]

  • 59. Importance of beta-lactamase induction.
    Phillips I, Shannon K.
    Eur J Clin Microbiol Infect Dis; 1993 Jun 15; 12 Suppl 1():S19-26. PubMed ID: 8477758
    [Abstract] [Full Text] [Related]

  • 60. The properties of beta-lactam antibiotics needed for therapeutic efficacy.
    Richmond MH.
    Prog Clin Biol Res; 1979 Jun 15; 35():17-25. PubMed ID: 317154
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.